The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications. Curr Radiopharm. 2018;11(3):154-155 Authors: Radchenko V, Schaffer P, Knapp FFR Abstract PMID: 30378473 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30378473?dopt=Abstract

Source: Current Radiopharmaceuticals - November 2, 2018 Category: Radiology Tags: Curr Radiopharm Source Type: research

More News: Radiology